HomeTOP STORIESAstraZeneca, Daiichi win EU backing for breast cancer drug Dato-DXd AstraZeneca, Daiichi win EU backing for breast cancer drug Dato-DXd By rogerjudd January 31, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleAvery Dennison upgraded at J.P. Morgan on expectation of upward price correctionNext articleBrookfield Business Partners swings to net loss in Q4 as revenue slides latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
